封面
市场调查报告书
商品编码
1370295

基因组学市场:2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Genomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

抽象的

市场概况:

2022年全球基因组学市场规模达294亿美元。展望未来,IMARC Group预计到2028年市场规模将达到688亿美元,2023-2028年复合年增长率(CAGR)为15%。

基因组学是对个体的功能、图谱、结构、演化和基因组(基因)的研究。它依赖诊断、药物发现、精准医学开发和农业研究的消耗品、系统、软体和服务。它有助于提供诊断和预测见解,帮助医疗保健专业人员研究并最终确定阿兹海默症、糖尿病和癌症等疾病的治疗方案。因此,它在世界各地被用于研究生物系统和解决医院、私人诊所、诊断和研究中心的复杂遗传问题。

基因组领域的显着进步、大众中慢性和传染病患者病率的增加以及对个人化药物的偏好不断增加是推动市场成长的主要因素。这也可以归因于越来越多地采用基于非侵入性癌症筛检的研究。此外,全球人口不断增长、气候条件不断变化、粮食安全问题日益严重,以及人们对化学肥料有害影响的认识不断提高,都推动了基因组学提高作物产量的需求。这与消费者对有机食品的偏好不断变化相结合,促进了市场的成长。此外,生物技术研发(R&D)投资的扩大,加上医疗基础设施和诊断技术的广泛改进,正在为市场创造积极的前景。除此之外,基于基因组学的应用程式和检测 DNA 改变的集成为行业投资者提供了利润丰厚的成长机会。

本报告回答的关键问题

  • 2022 年全球基因体学市场规模有多大?
  • 2023-2028年全球基因组市场的预期成长率是多少?
  • 推动全球基因组学市场的关键因素是什么?
  • COVID-19 对全球基因体学市场有何影响?
  • 全球基因组学市场按组成部分划分是怎样的?
  • 根据应用,全球基因组学市场的细分如何?
  • 基于该技术的全球基因组学市场的分化是什么?
  • 基于最终用户的全球基因组学市场的细分是什么?
  • 全球基因组学市场的关键区域有哪些?
  • 谁是全球基因组学市场的主要参与者/公司?

目录

第一章:前言

第 2 章:范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章:执行摘要

第 4 章:简介

  • 概述
  • 主要行业趋势

第 5 章:全球基因组市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章:按成分分類的市场区隔

  • 产品
    • 市场走向
    • 主要类型
      • 仪器和软体
      • 耗材和试剂
    • 市场预测
  • 服务
    • 市场走向
    • 主要类型
      • 核心基因组学服务
      • 基于 NGS 的服务
      • 生物标誌物翻译服务
      • 计算服务
      • 其他的
    • 市场预测

第 7 章:按应用分類的市场区隔

  • 功能基因体学
    • 市场走向
    • 市场预测
  • 表观基因组学
    • 市场走向
    • 市场预测
  • 生物标记发现
    • 市场走向
    • 市场预测
  • 通路分析
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章:依科技分類的市场

  • 定序
    • 市场走向
    • 市场预测
  • 微阵列
    • 市场走向
    • 市场预测
  • 聚合酶炼式反应
    • 市场走向
    • 市场预测
  • 核酸萃取与纯化
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章:最终用户的市场区隔

  • 研究中心
    • 市场走向
    • 市场预测
  • 医院和诊所
    • 市场走向
    • 市场预测
  • 製药和生物技术公司
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章:按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太地区
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 11 章:SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章:价值链分析

第 13 章:波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章:价格指标

第15章:竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • 23andMe, Inc.
    • Agilent Technologies, Inc.
    • Bayer Aktiengesellschaft
    • BGI Genomics Co. Ltd.
    • Bio-RAD Laboratories Inc.
    • Danaher Corporation
    • Illumina Inc.
    • Oxford Nanopore Technologies
    • PerkinElmer Inc.
    • Myriad Genetics Inc.
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A2246

Abstract

Market Overview:

The global genomics market size reached US$ 29.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 68.8 Billion by 2028, exhibiting a growth rate (CAGR) of 15% during 2023-2028.

Genomics is the study of the function, mapping, structure, evolution, and genomes (genes) of an individual. It relies on consumables, systems, software, and services for diagnostics, drug discovery, development of precision medicine, and agricultural research. It aids in providing diagnostic and predictive insights that help healthcare professionals in research and finalizing treatment options for diseases, such as Alzheimer's, diabetes, and cancer. As a result, it is utilized around the world in studying biological systems and solving complex genetic problems in hospitals, private clinics, diagnostic, and research centers.

Significant advancements in the genomic field, increasing prevalence of chronic and infectious disorders among the masses, and rising preferences for personalized medicines are major factors bolstering the market growth. It can also be attributed to the growing adoption of non-invasive cancer screening-based research. In addition, the expanding global population, changing climatic conditions, rising food security concerns, and spreading awareness about the harmful effects of chemical-based fertilizers are driving the need for genomics to improve crop yield. This, in confluence with the shifting consumer preferences for organic food products, is contributing to the market growth. Furthermore, expanding investments in research and development (R&D) of biotechnology, coupled with extensive improvements in medical infrastructure and diagnostic technologies, are creating a positive outlook for the market. Apart from this, the integration of genomics-based apps and tests to identify DNA alterations is offering lucrative growth opportunities to industry investors.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global genomics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on component, application, technology, and end-user.

Breakup by Component:

Products

Instruments and Software

Consumables and Reagents

Services

Core Genomics Services

NGS-Based Services

Biomarker Translation Services

Computational Services

Others

Consumables and reagents hold the biggest market share as they aid in performing single-molecule and real-time (SMRT) sequencing.

Breakup by Application:

Functional Genomics

Epigenomics

Biomarkers Discovery

Pathway Analysis

Others

Functional genomics dominates the application segment as they help improve crop plants, human health, and livestock.

Breakup by Technology:

Sequencing

Microarray

Polymerase Chain Reaction

Nucleic Acid Extraction and Purification

Others

Sequencing exhibits a clear dominance in the market as it provides information on genetic variants that can lead to different diseases.

Breakup by End-User:

Research Centers

Hospitals and Clinics

Pharmaceutical and Biotechnology Companies

Others

Pharmaceutical and biotechnology companies hold the majority of the total market share as they help modify genes and provide a new platform for the high-throughput genetic analysis of forest trees.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America holds the majority of the global genomics market share on account of increasing preferences for personalized medicines.

Competitive Landscape:

The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are 23andMe, Inc, Agilent Technologies, Inc., Bayer AG, BGI Group, Bio-Rad Laboratories, Inc., Danaher Corporation, Illumina, Inc., Oxford Nanopore Technologies, PerkinElmer, Inc., Myriad Genetics, Inc., F. Hoffmann-La Roche Ltd, and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global genomics market in 2022?
  • 2. What is the expected growth rate of the global genomics market during 2023-2028?
  • 3. What are the key factors driving the global genomics market?
  • 4. What has been the impact of COVID-19 on the global genomics market?
  • 5. What is the breakup of the global genomics market based on the component?
  • 6. What is the breakup of the global genomics market based on the application?
  • 7. What is the breakup of the global genomics market based on the technology?
  • 8. What is the breakup of the global genomics market based on the end-user?
  • 9. What are the key regions in the global genomics market?
  • 10. Who are the key players/companies in the global genomics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Genomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Products
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Instruments and Software
      • 6.1.2.2 Consumables and Reagents
    • 6.1.3 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Core Genomics Services
      • 6.2.2.2 NGS-Based Services
      • 6.2.2.3 Biomarker Translation Services
      • 6.2.2.4 Computational Services
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Functional Genomics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Epigenomics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biomarkers Discovery
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pathway Analysis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Sequencing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Microarray
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Polymerase Chain Reaction
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Nucleic Acid Extraction and Purification
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Research Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals and Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 23andMe, Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Agilent Technologies, Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer Aktiengesellschaft
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 BGI Genomics Co. Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Bio-RAD Laboratories Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Danaher Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Illumina Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Oxford Nanopore Technologies
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 PerkinElmer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Myriad Genetics Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Roche Holding AG
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Genomics Market: Major Drivers and Challenges
  • Figure 2: Global: Genomics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Genomics Market: Breakup by Component (in %), 2022
  • Figure 4: Global: Genomics Market: Breakup by Application (in %), 2022
  • Figure 5: Global: Genomics Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Genomics Market: Breakup by End-User (in %), 2022
  • Figure 7: Global: Genomics Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Genomics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 9: Global: Genomics (Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Genomics (Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Genomics (Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Genomics (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Genomics (Functional Genomics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Genomics (Functional Genomics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Genomics (Epigenomics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Genomics (Epigenomics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Genomics (Biomarkers Discovery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Genomics (Biomarkers Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Genomics (Pathway Analysis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Genomics (Pathway Analysis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Genomics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Genomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Genomics (Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Genomics (Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Genomics (Microarray) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Genomics (Microarray) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Genomics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Genomics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Genomics (Nucleic Acid Extraction and Purification) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Genomics (Nucleic Acid Extraction and Purification) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Genomics (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Genomics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Genomics (Research Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Genomics (Research Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Genomics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Genomics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Genomics (Other End-Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Genomics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: North America: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: North America: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: United States: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: United States: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Canada: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Canada: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Asia Pacific: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Asia Pacific: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: China: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: China: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Japan: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Japan: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: India: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: India: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: South Korea: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: South Korea: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Australia: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Australia: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Indonesia: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Indonesia: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Others: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Others: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Europe: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Europe: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Germany: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Germany: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: France: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: France: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: United Kingdom: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: United Kingdom: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Italy: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Italy: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Spain: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Spain: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Russia: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Russia: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Others: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Others: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Latin America: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Latin America: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Brazil: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Brazil: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Mexico: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Mexico: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Others: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Others: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Middle East and Africa: Genomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Middle East and Africa: Genomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Global: Genomics Industry: SWOT Analysis
  • Figure 90: Global: Genomics Industry: Value Chain Analysis
  • Figure 91: Global: Genomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Genomics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Genomics Market Forecast: Breakup by Component (in Million US$), 2023-2028
  • Table 3: Global: Genomics Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Genomics Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 5: Global: Genomics Market Forecast: Breakup by End-User (in Million US$), 2023-2028
  • Table 6: Global: Genomics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Genomics Market: Competitive Structure
  • Table 8: Global: Genomics Market: Key Players